Quality assurance management no longer needs to convince the C-suite of its contribution to the bottom line, says Lusi Zheng, senior director of quality assurance, with Gartner.
The focus by companies on fulfilling basic orders during the COVID-19 pandemic has allowed a more insidious problem to come to a head: the influx of gray-market products into the supply chain.
Despite the challenges higher fuel costs bring to industries, few companies have made significant efforts to address the issue. Fortunately, there are ways to mitigate the worst effects of the cost burden.
Companies seeking to decarbonize their supply chains will never reach that goal without the help of suppliers over which they assert no direct control.
Amid strained supply chains, heightened consumer demand, increased regulatory scrutiny and looming economic factors, companies must monitor for changes and implement clear procedures to ensure product safety in today’s environment.
Now is the time to embrace strategies that set healthcare facilities up for success, regardless of whether there’s a surplus or shortage of crucial medical supplies.